Arnhem, Netherlands

Theodorus Hendricus Antonius Peters


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2001-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Theodorus Hendricus Antonius Peters: Innovator in Pharmaceutical Chemistry

Introduction

Theodorus Hendricus Antonius Peters is a notable inventor based in Arnhem, Netherlands. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds and processes. With a total of 3 patents to his name, Peters has demonstrated a commitment to innovation and scientific advancement.

Latest Patents

Peters' latest patents include a process for the preparation of 2-amino-6 (alkyl) amino-4,5,6,7-tetrahydrobenzothiazoles. This new process describes the synthesis of pramipexole and related products through the reaction of specific compounds with alkylamines in the presence of reducing agents or hydrogen gas with a hydrogenation catalyst. Additionally, he has developed imidazopyridine derivatives, which can be produced in high purity using a novel intermediate. These advancements highlight his expertise in creating efficient and effective chemical processes.

Career Highlights

Throughout his career, Peters has worked with Synthon B.V., a company known for its focus on pharmaceutical development. His work has contributed to the advancement of various therapeutic compounds, showcasing his ability to innovate within the pharmaceutical industry.

Collaborations

Peters has collaborated with notable colleagues, including Jacobus Maria Lemmens and Gerrit Jan Bouke Ettema. These partnerships have likely enhanced his research and development efforts, leading to successful patent applications and innovative solutions in pharmaceutical chemistry.

Conclusion

Theodorus Hendricus Antonius Peters is a distinguished inventor whose work in pharmaceutical chemistry has led to significant advancements in the field. His innovative processes and collaborations reflect his dedication to improving therapeutic compounds and contributing to scientific progress.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…